Cargando…
The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer
PURPOSE: Study reported that C-reactive protein (CRP) would peak at 48 h after the initiation of an acute inflammatory response. We proposed that the ratio of CRP level on postoperative day 3 to day 2 (POD3/2 CRP) can be used to early predict major postoperative complications (PCs) for patients who...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283359/ https://www.ncbi.nlm.nih.gov/pubmed/35199220 http://dx.doi.org/10.1007/s00423-022-02469-w |
_version_ | 1784747294552227840 |
---|---|
author | Luo, Bin Liao, Qianchao Zheng, Jiabin Hu, Weixian Yao, Xueqing Li, Yong Wang, Junjiang |
author_facet | Luo, Bin Liao, Qianchao Zheng, Jiabin Hu, Weixian Yao, Xueqing Li, Yong Wang, Junjiang |
author_sort | Luo, Bin |
collection | PubMed |
description | PURPOSE: Study reported that C-reactive protein (CRP) would peak at 48 h after the initiation of an acute inflammatory response. We proposed that the ratio of CRP level on postoperative day 3 to day 2 (POD3/2 CRP) can be used to early predict major postoperative complications (PCs) for patients who underwent laparoscopic radical gastrectomy. METHODS: Patients were randomized into training cohort and validation cohort at a ratio of 7:3. PCs greater than grade II or more, according to Clavien-Dindo classification, were defined as major PCs. Three predictive models for major PCs based on CRP level were constructed, including POD3/2 CRP, the CRP level on POD3 (POD3 CRP), and the ratio of CRP level on POD3 to POD1 (POD3/1 CRP). The performances of three prediction models were assessed by AUC. Univariate and multivariate logistic regression analyses were performed to identify risk factors of major PCs. RESULTS: 344 patients were included. Major PCs were observed in 57 patients (16.6%). In the training cohort, POD3/2 CRP provided the best diagnostic accuracy with an AUC of 0.929 at an optimal cut-off value of 1.08, and the sensitivity and specificity were 0.902 and 0.880, respectively. In the validation cohort, the corresponding AUC was 0.917. BMI ≥ 25 kg/m(2) and POD3/2 CRP > 1 were identified as risk factors for major PCs. CONCLUSION: POD3/2 CRP is a reliable marker to predict major PCs after laparoscopic radical gastrectomy. If CRP is higher on POD3 than on POD2, major PCs are highly likely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-022-02469-w. |
format | Online Article Text |
id | pubmed-9283359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-92833592022-07-16 The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer Luo, Bin Liao, Qianchao Zheng, Jiabin Hu, Weixian Yao, Xueqing Li, Yong Wang, Junjiang Langenbecks Arch Surg Original Article PURPOSE: Study reported that C-reactive protein (CRP) would peak at 48 h after the initiation of an acute inflammatory response. We proposed that the ratio of CRP level on postoperative day 3 to day 2 (POD3/2 CRP) can be used to early predict major postoperative complications (PCs) for patients who underwent laparoscopic radical gastrectomy. METHODS: Patients were randomized into training cohort and validation cohort at a ratio of 7:3. PCs greater than grade II or more, according to Clavien-Dindo classification, were defined as major PCs. Three predictive models for major PCs based on CRP level were constructed, including POD3/2 CRP, the CRP level on POD3 (POD3 CRP), and the ratio of CRP level on POD3 to POD1 (POD3/1 CRP). The performances of three prediction models were assessed by AUC. Univariate and multivariate logistic regression analyses were performed to identify risk factors of major PCs. RESULTS: 344 patients were included. Major PCs were observed in 57 patients (16.6%). In the training cohort, POD3/2 CRP provided the best diagnostic accuracy with an AUC of 0.929 at an optimal cut-off value of 1.08, and the sensitivity and specificity were 0.902 and 0.880, respectively. In the validation cohort, the corresponding AUC was 0.917. BMI ≥ 25 kg/m(2) and POD3/2 CRP > 1 were identified as risk factors for major PCs. CONCLUSION: POD3/2 CRP is a reliable marker to predict major PCs after laparoscopic radical gastrectomy. If CRP is higher on POD3 than on POD2, major PCs are highly likely. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-022-02469-w. Springer Berlin Heidelberg 2022-02-23 2022 /pmc/articles/PMC9283359/ /pubmed/35199220 http://dx.doi.org/10.1007/s00423-022-02469-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Luo, Bin Liao, Qianchao Zheng, Jiabin Hu, Weixian Yao, Xueqing Li, Yong Wang, Junjiang The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer |
title | The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer |
title_full | The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer |
title_fullStr | The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer |
title_full_unstemmed | The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer |
title_short | The ratio of serum C-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer |
title_sort | ratio of serum c-reactive protein level on postoperative day 3 to day 2 is a good marker to predict postoperative complications after laparoscopic radical gastrectomy for gastric cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283359/ https://www.ncbi.nlm.nih.gov/pubmed/35199220 http://dx.doi.org/10.1007/s00423-022-02469-w |
work_keys_str_mv | AT luobin theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT liaoqianchao theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT zhengjiabin theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT huweixian theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT yaoxueqing theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT liyong theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT wangjunjiang theratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT luobin ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT liaoqianchao ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT zhengjiabin ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT huweixian ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT yaoxueqing ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT liyong ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer AT wangjunjiang ratioofserumcreactiveproteinlevelonpostoperativeday3today2isagoodmarkertopredictpostoperativecomplicationsafterlaparoscopicradicalgastrectomyforgastriccancer |